Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
US: Racial gap exists when docs talk to patients about HIV meds

Conversations between doctors and patients about taking HIV medication as prescribed may differ depending on the patient’s race or ethnicity, research shows. Providers talked more with minority patients than with whites about adherence and tended to give directives rather than engage in problem solving.

Published
29 January 2014
From
Futurity
Average CD4 cell count at time HIV therapy was started increased among young people in New York City after 2009

The average CD4 cell count at which young people living with HIV in New York City started antiretroviral therapy increased significantly after US guidelines changed in late

Published
29 January 2014
By
Michael Carter
Successful HIV drug resistance testing is possible when viral load is low

HIV drug resistance testing can perform well, even when viral load is as low as 250 copies/ml, results of two studies published in the online edition of

Published
27 January 2014
By
Michael Carter
Antiretroviral treatment French guidelines 2013: economics influencing science

In the new French guidelines, economic considerations significantly influence and, in some instances, take precedence over the scientific evidence, leading to guidelines that are significantly different from those of other national and international committees.

Published
27 January 2014
From
Journal of Antimicrobial Chemotherapy
Ongoing challenges in providing PMTCT in Kenya and Malawi

Ongoing systemic issues are affecting the implementation of the 2010 World Health Organisation (WHO) guidelines on prevention of mother-to-child transmission (PMTCT) programmes in Kenya, according to a study

Published
24 January 2014
By
Lesley Odendal
Significant attrition at each step of the HIV care 'cascade' in British Columbia

Patients are being lost at each stage of the HIV care ‘cascade’ in British Columbia, Canada. Investigators from the STOP HIV/AIDS Study group examined data from 1996

Published
23 January 2014
By
Michael Carter
Victrelis (boceprevir) label changes update contraindications and drug interactions

On January 17, 2014, FDA approved changes to the Victrelis (boceprevir) package insert to expand the list of contraindicated medications and update the Drug Interaction section.

Published
23 January 2014
From
FDA
Perry N. Halkitis: Does Treatment As Prevention Care for the HIV-positive?

I would like to think that those advocating treatment as prevention ultimately have the health of HIV-positive individuals in mind first and foremost. But my immersion into the UK system this last month has led me to wonder about the motivation that underlies this approach.

Published
22 January 2014
From
Huffington Post
Quality Of Evidence Used By FDA To Approve New Drugs Varies Widely

As the FDA seeks to approve drugs not only more quickly but also accommodate a growing clamor to exhibit more flexibility for endorsing therapies for life-threatening diseases, a curious wrinkle has emerged – there is a wide variation in the quality of underlying evidence used for approvals.

Published
22 January 2014
From
Forbes
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe

ViiV Healthcare today announced that the European Commission has approved Tivicay™ (dolutegravir), an integrase inhibitor, for use in combination with other anti-retroviral medicinal products for the treatment of HIV infected adults and adolescents above 12 years of age.

Published
21 January 2014
From
ViiV Healthcare press release

Filter by country